SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,957.27 -307.24
( -0.40%)

Global Indices

Nasdaq

53,569.16 -21.28
(-0.04%)

Dow Jones

7,731.77 -20.22
(-0.26%)

Hang Seng

66,147.06 -258.50
(-0.39%)

Nikkei 225

10,824.26 31.76
(0.29%)

Forex

USD-INR

95.48 0.22
(0.23%)

EUR-INR

111.24 0.16
(0.15%)

GBP-INR

129.74 0.04
(0.03%)

JPY-INR

0.60 0.00
(0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

276.4035981

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

44.11

1090.02

EPS(TTM)

Face Value()

Div & Yield %

20.97

0.05

Back

rawmin neo elements ltd

Swasti Vinayaka Art & Heritage Corporation standalone net profit declines 60.00% in the June 2026 quarter

Aug 15,2026

Net profit of Swasti Vinayaka Art & Heritage Corporation declined 60.00% to Rs 0.58 crore in the quarter ended June 2026 as against Rs 1.45 crore during the previous quarter ended June 2025. Sales declined 58.73% to Rs 4.11 crore in the quarter ended June 2026 as against Rs 9.96 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	4.11	9.96	-59
OPM %	18.73	24.00	-
PBDT	0.78	1.95	-60
PBT	0.76	1.93	-61
NP	0.58	1.45	-60

76,957.27 -307.24 ( -0.40%)

53,569.16 -21.28 (-0.04%)

7,731.77 -20.22 (-0.26%)

66,147.06 -258.50 (-0.39%)

10,824.26 31.76 (0.29%)

95.48 0.22 (0.23%)

111.24 0.16 (0.15%)

129.74 0.04 (0.03%)

0.60 0.00 (0.12%)